Showing results (91-100 of 368) with videos related to

Sort By:
Pageof 37
Current Treatment Options in Oncology|September 5, 2019
Diagnosis and Treatment of ALK Aberrations in Metastatic NSCLCAlex Friedlaender, Giuseppe Banna, Sandip Patel, et al.
Future Oncology (London, England)|October 23, 2024
Rates of febrile neutropenia and its causes in the real worldMaxime Borgeaud, Simona Perano, Alfredo Addeo, et al.
Cancer Journal (Sudbury, Mass.)|November 16, 2022
Antibody Drug Conjugates in Lung CancerGeoffrey Merle, Alex Friedlaender, Aakash Desai, et al.
Ecancermedicalscience|January 26, 2019
Learning from the past to design better trials in second-line treatment for mesothelioma patientsAlfredo Addeo, Giuseppe Luigi Banna, Pierre-Yves Dietrich
Cancer Genomics & Proteomics|August 30, 2020
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung CancerMathieu Chevallier, Petros Tsantoulis, Alfredo Addeo, et al.
Cancer Genomics & Proteomics|October 30, 2019
The Activity of Immune Checkpoint Inhibition in KRAS Mutated Non-small Cell Lung Cancer: A Single Centre ExperienceJavier Torralvo, Alex Friedlaender, Verane Achard, et al.
Frontiers in Oncology|May 6, 2022
The Landscape of Immunotherapy Resistance in NSCLCDaniele Frisone, Alex Friedlaender, Alfredo Addeo, et al.
World Journal of Clinical Oncology|May 7, 2021
Oncogenic driver mutations in non-small cell lung cancer: Past, present and futureMathieu Chevallier, Maxime Borgeaud, Alfredo Addeo, et al.
ESMO Open|November 5, 2020
Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancerNuria Mederos, Alex Friedlaender, Solange Peters, et al.
International Health|November 7, 2019
Prevalence of American Heart Association defined ideal cardiovascular health metrics in Nepal: findings from a nationally representative cross-sectional studyUmesh Ghimire, Nipun Shrestha, Bishal Gyawali, et al.
Pageof 37